Target intelligence / Profile preview

Prochemerin (precursor of chemerin)

Molecular classification
Precursor protein, Secreted protein, Adipokine precursor, Zymogen (inactive precursor to an active protein)
01

Overview

Prochemerin is the inactive, secreted precursor of chemerin, a protein produced by the *RARRES2* gene. It consists of 143 amino acids and requires proteolytic cleavage at the C-terminus by various proteases from the coagulation, fibrinolytic or inflammatory cascades to generate biologically active chemerin. Only the activated chemerin binds to and acts via its G protein-coupled receptors—especially CMKLR1 (ChemR23)—to mediate immune cell chemotaxis, adipocyte differentiation, metabolic regulation, and inflammatory signaling. Prochemerin does not bind chemerin receptors or directly mediate these biologic actions, but is the essential source protein for generating various chemerin isoforms with distinct activities[5][7][3]. Summary: "Prochemerin" is best described as an inactive precursor and not a therapeutically actionable target, receptor, or enzyme. All major biological, disease, and pharmacological roles are attributed to its processed product, chemerin, and especially to chemerin's interaction with GPCRs (e.g., CMKLR1/ChemR23). If your use case is therapeutic targeting, data capture, or biomarker study, you likely want to focus on "chemerin" or its receptors, not "prochemerin"[5][7][3][4].

Other names
Pro-chemerinprochemerinchemoattractant protein precursor
02

Biological functions

Precursor for chemerin (which regulates immune cell chemotaxis, adipogenesis, and inflammation)No direct biological activity until processed
03

Disease associations

Precursor forms are relevant in disease only as sources of active chemerin; chemerin (after activation) is associated with obesity, diabetes, inflammation, cancer, cardiovascular disease
04

Biomarkers

Circulating levels of chemerin (after processing from prochemerin) can be biomarkers for metabolic disease, inflammation, hypertensionProchemerin itself is rarely measured as a clinical biomarker

Beyond the preview

Go deeper on Prochemerin (precursor of chemerin).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prochemerin (precursor of chemerin).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call